News from cellular biomedicine group A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Dec 13, 2013, 15:33 ET

Cellular Biomedicine Group Announces Completion of Patient Treatment for Phase I Clinical Trial for Liver Cancer

Cellular Biomedicine Group, Inc. (OTCQB: CBMG),  a biomedicine firm engaged in the development of new treatments for degenerative and...

Nov 09, 2013, 05:55 ET

Cellular Biomedicine Group Announces Adjournment of Its Annual Shareholder Meeting

 Cellular Biomedicine Group, Inc. (OTCQB: CBMG) today convened the annual meeting of its shareholders. Because a quorum was not achieved by...

Nov 07, 2013, 14:45 ET

Cellular Biomedicine Group Announces November 07, 2013 as Voting Deadline for Its Annual Shareholder Meeting

 Cellular Biomedicine Group, Inc. (OTCQB: CBMG) today reminded all its shareholders that the Board of the Company has set November 08, 2013 as...

Nov 05, 2013, 11:36 ET

Cellular Biomedicine Group Receives Approval for Phase IIb Clinical Trial of ReJoin™ for Treatment of Knee Osteoarthritis (KOA)

 Cellular Biomedicine Group, Inc. (OTCQB: CBMG), a biomedicine firm engaged in the development of new treatments for degenerative and cancerous...

Nov 01, 2013, 10:01 ET

Cellular Biomedicine Group Announces Completion of Patient Treatment for Phase I/IIa Clinical Trial for Treatment of Knee Osteoarthritis (KOA)

Cellular Biomedicine Group, Inc. (OTCQB: CBMG) is pleased to announce that it has treated the final patient of its Phase I/IIa clinical trial for...

Oct 30, 2013, 09:01 ET

Cellular Biomedicine Group Announces New Product Approved for Market in China and New Exclusive License

Today Cellular Biomedicine Group (OTCQB:CBMG) announced that their A-Stromal™ adipose stromal cell purification kit is ready to launch on the...

Oct 25, 2013, 10:08 ET

Cellular Biomedicine Group calls for General Annual Shareholder Meeting on November 08, 2013

 Cellular Biomedicine Group, Inc. (OTCQB:CBMG) today announced that the Board of the Company has set November 08, 2013 as the date for the...

Oct 14, 2013, 09:44 ET

Cellular Biomedicine Group Appoints Three Independent Directors to the Board

Cellular Biomedicine Group, Inc. (OTCQB: CBMG) today announced that the Board of the Company has appointed three new independent directors to the...

Oct 01, 2013, 07:50 ET

Cellular Biomedicine Group Announces Appointment of New CEO

 Cellular Biomedicine Group, Inc. (OTCQB: CBMG) announced today that it has promoted Dr. Wei (William) Cao to serve as its Chief Executive...

Sep 11, 2013, 09:28 ET

Cellular Biomedicine Group Announces Change of Auditor

Cellular Biomedicine Group, Inc. (OTCQB: CBMG), a biomedicine firm engaged in the development of new treatments for degenerative and...

Sep 06, 2013, 07:00 ET

Cellular Biomedicine Group Announces Positive Interim Results from Phase I/IIa Clinical Trial for Treatment of Knee Osteoarthritis (KOA)

 Cellular Biomedicine Group, Inc. (OTCQB: CBMG) today announced the interim results of its Phase I/IIa clinical trial for human adipose-derived...

Aug 22, 2013, 11:48 ET

Cellular Biomedicine Group Announces Completion of Patient Enrollment for Phase I Clinical Trial for Liver Cancer

 Cellular Biomedicine Group (OTCQB: CBMG) today announced that it has completed patient enrollment for its Phase I trial to evaluate the safety...

Aug 16, 2013, 11:17 ET

Cellular Biomedicine Group Reports Second Quarter and First Half 2013 Financial Results and Business Highlights

 Cellular Biomedicine Group, Inc. (OTCQB: CBMG), a developer of proprietary cell therapies for the treatment of degenerative diseases and...

Jul 22, 2013, 10:25 ET

Cellular Biomedicine Group Completes Enrollment in Phase I Clinical Trial for Knee Osteoarthritis

Cellular Biomedicine Group (OTCQB:CBMG) today announced that it has completed the enrollment required for its Phase I trial to evaluate the safety...

Jul 11, 2013, 14:39 ET

Cellular Biomedicine Group Appoints Director of Medical Research

 Cellular Biomedicine Group, Inc. (OTCQB: CBMG), a biomedicine firm engaged in the development of new treatments for degenerative and cancerous...

Jun 13, 2013, 07:18 ET

Cellular Biomedicine Group Announces Expansion in the Osteoarthritis and Rheumatoid Arthritis Market

Cellular Biomedicine Group, Inc. (OTCQB: CBMG), a biomedicine firm engaged in the development of new treatments for degenerative and cancerous...

Jun 06, 2013, 07:58 ET

Cellular Biomedicine Group Announces Appointment of Corporate Controller

Cellular Biomedicine Group, Inc. (OTCQB:CBMG), a biomedicine firm engaged in the development of new treatments for degenerative and cancerous...

May 22, 2013, 08:01 ET

Cellular Biomedicine Group Announces Enrollment Milestone for Phase I Clinical Trial for Liver Cancer

Cellular Biomedicine Group (OTCQB: CBMG) today announced that it has achieved half of the enrollment of the total projected enrollment required for...

May 17, 2013, 08:44 ET

Cellular Biomedicine Group Achieves 50% Enrollment Milestone in Phase I Clinical Trial for Knee Osteoarthritis

 Cellular Biomedicine Group (OTCQB: CBMG) today announced that it has achieved 50% enrollment of the total projected enrollment required for...

Apr 25, 2013, 07:16 ET

Cellular Biomedicine Group Provides Update and 2013 Milestones

 Cellular Biomedicine Group, Inc. (CBMG), a developer of proprietary cell therapies for the treatment of degenerative diseases and cancers,...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

ReportBuyer
Research and Markets
Investor-Edge